Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 26, 2015
Dr. Marnix L. Bosch, Chief Technical Officer of Northwest Biotherapeutics, presents encouraging new data on DCVax-L "Informational Arm" patients, who were excluded from the trial for the reasons of suspected real or pseudo progression. March, 2015. Munich, Germany.